{"filing":{"accession_number":"0001104659-26-089037","cik":"0002072188","ticker":"BIOT","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","form":"6-K","filing_date":"2026-07-31","report_date":"2026-07-31","primary_document":"tm2621810d1_6k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/2072188/000110465926089037/tm2621810d1_6k.htm"},"events":[{"id":22335,"run_id":20197,"accession_number":"0001104659-26-089037","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"The exhibit discloses a strategic collaboration (Memorandum of Agreement) between Instinct Bio's subsidiaries and INVITRX to expand the GENRÊVER cosmetic product line into the U.S. market and develop regenerative medicine initiatives in Indonesia. This is a material operational and strategic partnership that would affect investor assessment of the company's growth trajectory and market expansion plans, but it does not fit the specific event categories of M\u0026A activity (no acquisition/merger/change of control), debt issuance, or other defined event types. The collaboration is material as it represents a significant strategic initiative for international expansion, but the domain is clearly operational/strategic rather than financial, governance, or legal.","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-07-31","form":"6-K","submitted_at":null,"items":[{"id":22254,"accession_number":"0001104659-26-089037","item_number":"EX-99.1","item_title":"tm2621810d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The exhibit discloses a strategic collaboration (Memorandum of Agreement) between Instinct Bio's subsidiaries and INVITRX to expand the GENRÊVER cosmetic product line into the U.S. market and develop regenerative medicine initiatives in Indonesia. This is a material operational and strategic partnership that would affect investor assessment of the company's growth trajectory and market expansion plans, but it does not fit the specific event categories of M\u0026A activity (no acquisition/merger/change of control), debt issuance, or other defined event types. The collaboration is material as it represents a significant strategic initiative for international expansion, but the domain is clearly operational/strategic rather than financial, governance, or legal.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:04:14.919279+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":22254,"accession_number":"0001104659-26-089037","item_number":"EX-99.1","item_title":"tm2621810d1_ex99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The exhibit discloses a strategic collaboration (Memorandum of Agreement) between Instinct Bio's subsidiaries and INVITRX to expand the GENRÊVER cosmetic product line into the U.S. market and develop regenerative medicine initiatives in Indonesia. This is a material operational and strategic partnership that would affect investor assessment of the company's growth trajectory and market expansion plans, but it does not fit the specific event categories of M\u0026A activity (no acquisition/merger/change of control), debt issuance, or other defined event types. The collaboration is material as it represents a significant strategic initiative for international expansion, but the domain is clearly operational/strategic rather than financial, governance, or legal.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-08-01T00:04:14.919279+00:00","company_name":"INSTINCT BIO TECHNICAL CO HOLDINGS INC.","ticker":"BIOT","filing_date":"2026-07-31"}]}